Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Corticosteroid Rhythms in Hypoparathyroid Patients
NCT02986607Phase 1Unknown
- Sponsor
- University of Bergen
- Start
- Mar 2016
- Primary completion
- Jan 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, open-label trial of parathyroid hormone 1-84 in hypoparathyroidism (3 arms), sponsored by University of Bergen. Primary endpoint: Corticosteroid secretion in hypoparathyroid patients at 1 week. Status: unknown.
02
Drugs
parathyroid hormone 1-84
03
Conditions
hypoparathyroidism
Beyond the preview
Go deeper on NCT02986607.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02986607.